Response to AASLD editorial/message from the president. (CROSBI ID 255198)
Prilog u časopisu | Pismo (znanstveno) | međunarodna recenzija
Podaci o odgovornosti
Koretz, Ronald ; Jakobsen, Janus ; Hauser, Goran ; Nikolova, Dimitrinka ; Gluud, Christian
Cochrane Hepato-Biliary Group
engleski
Response to AASLD editorial/message from the president.
A commentary [1] criticized our systematic review regarding the use of direct-acting agents (DAAs) in chronic hepatitis C [2]. The following represents our major disagreements. Sustained virological response (SVR) is a non-validated surrogate outcome. The principles of evidence-based medicine require that it be validated in randomized clinical trials (RCTs) by showing parallel benefits in clinical outcomes [3]. This article is protected by copyright. All rights reserved.
Hepatitis C ; Sustained virological response
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
Povezanost rada
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)